grant

QC and Release Testing of Vector and Cell Clinical Gene Therapy Products

Organization DIVISION OF BASIC SCIENCES - NCILocation UNITED STATES
NIHUS FederalResearch GrantFY2025AllogenicAnnual ReportsAntigen-Presenting CellsAssayAutologousB blood cellsB cellB cellsB-CellsB-LymphocytesB-cellBioassayBiological AssayCRADACell BodyCellsClinicalComplexContracting OpportunitiesContractsCooperative Research and Development AgreementDNA TherapyDataDetectionDevelopmentDisease ProgressionEndotoxinsEnsureEperythrozoonFailureGene Transfer ClinicalGenetic InterventionGood Manufacturing ProcessGood manufacturing practiceHaemobartonellaIndividualInfusionInfusion proceduresLeadManufactured MaterialsMicrobiologyMolecularMycoplasmaOperative ProceduresOperative Surgical ProceduresPatient SchedulesPatientsPb elementPlasmidsProcessProductionQualifyingQuality ControlReagentReportingResearchResidualResidual stateRetroviridaeRetrovirusesSafetySpecific qualifier valueSpecificitySpecifiedSterilitySurgicalSurgical InterventionsSurgical ProcedureTestingTimeTreatment ProtocolsTreatment RegimenTreatment ScheduleViralVirusVirus-RetrovirusWorkaccessory cellcustomized therapycustomized treatmentdevelopmentalendonucleasegene productgene repair therapygene therapygene-based therapygenetic therapygenomic therapyheavy metal Pbheavy metal leadindividualized medicineindividualized patient treatmentindividualized therapeutic strategyindividualized therapyindividualized treatmentinfusionsmanufacturemanufacturing organizationnovelpatient specific therapiespatient specific treatmentpersonalization of treatmentpersonalized medicinepersonalized therapypersonalized treatmentsterilesurgerytailored medical treatmenttailored therapytailored treatmenttimelinetransduction efficiencyunique treatmentvector
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

The release of clinical vector/virus and cell products requires the execution of several concurrent, time sensitive assays by the Surgery Branch Quality Control Unit. These assays demonstrate appropriate conformance to specification metrics of products manufactured both at the Surgery Branch and from external labs such as Contract Manufacturing…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
QC and Release Testing of Vector and Cell Clinical Gene Therapy Products — DIVISION OF BASIC SCIENCES - NCI | UNITED STA | Dev Procure